Investment
Features
FeesSafety
Academy
More
Pluang+

Orthocell's US sales of nerve repair product Remplir rise 25% in Q3, driving global revenue growth.

Market News
21 Oct 2026
Proactive Investors
View Source
Bullish
Orthocell's US sales of nerve repair product Remplir rise 25% in Q3, driving global revenue growth.

Orthocell Ltd reported a 25% increase in US sales of its nerve repair product Remplir in the September quarter, boosting global Remplir revenue by 20% to over 40% of total revenue. The company expanded its US commercial network to cover 70% of the population and increased hospital and surgeon adoption. Orthocell also made its first Remplir sales in Thailand and is preparing for UK and European market entry by the end of 2026. With a strong financial position of A$39 million in available funds, Orthocell aims to grow repeat usage in the US and secure further approvals while advancing clinical evidence for Remplir's applications.

Orthocell's US Remplir sales momentum is noted alongside Pluang's health sector snapshot. As of Oct 22, 2026 06:41 WIB, out of 150 priced US health stocks, 70 rose and 78 fell. Among movers, Illumina (ILMN) rose 5.65% to USD 283.08 with 68% buy orders and a typical hold time of 83 days, contrasting with Nuwellis (NUWE) down 5.37% at USD 0.52 but with 100% buy orders and a shorter hold time of 29 days, while 10X Genomics (TXG) gained 5.30% to USD 75.25 with full buy interest and a hold time of 92 days.

More News

Senteon wins Best Patch and Configuration Management award at 2026 Top InfoSec Innovator Awards

Senteon wins Best Patch and Configuration Management award at 2026 Top InfoSec Innovator Awards

Senteon was awarded the Best Solution Patch and Configuration Management at the 2026 Top InfoSec Innovator Awards by Cyber Defense Magazine. The company’s platform automates endpoint hardening and continuously monitors security configurations to redu...

Others
Neutral
1 hour ago
RENK sells slide bearings business to Miba, focusing on defense sector growth.

RENK sells slide bearings business to Miba, focusing on defense sector growth.

RENK Group AG has sold its slide bearings business to Austrian company Miba AG to sharpen its focus on the defense sector, aiming to increase defense-related revenue to 90% by 2030. The sale does not affect RENK's Marine & Industry civilian business,...

Company Fundamentals
Bullish
1 hour ago
RENK sells its slide bearings business to Miba to focus on defense sector growth

RENK sells its slide bearings business to Miba to focus on defense sector growth

RENK Group AG is selling its slide bearings business to Austrian company Miba AG as part of a strategic shift to focus more on its defense sector. The sale supports RENK's plan to increase defense-related revenue to about 90% by 2030, while the civil...

Company Fundamentals
Bullish
1 hour ago
RENK sells Slide Bearings business to Miba AG, focusing more on defense sector.

RENK sells Slide Bearings business to Miba AG, focusing more on defense sector.

RENK Group AG, through its subsidiary RENK GmbH, has signed a binding agreement to sell its Slide Bearings business to Austria's Miba AG. The Slide Bearings segment produces standardized bearings used mainly in industrial and civil markets. This sale...

Company Fundamentals
Neutral
1 hour ago
RENK sells its Slide Bearings business to Miba AG, focusing more on defense sector.

RENK sells its Slide Bearings business to Miba AG, focusing more on defense sector.

RENK Group AG, through its subsidiary RENK GmbH, has signed a binding agreement to sell its Slide Bearings business to Austria's Miba AG. This unit produces slide bearings mainly used in industrial and civilian markets. The sale aligns with RENK's 20...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App